Aerovate Therapeutics • AVTE
Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Timothy P. Noyes$602.4M
Market Cap • 18/04/20242018
(há 6 anos)
2021
(3 years ago)
NASDAQ
Listagem
Waltham
Sede • Massachusetts43
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
AVTESó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.